Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION
Home Page >> Invokana Linked with Cardiovascular Injuries and Kidney Failure >> Articles >> Lawyer Interviews

Invokana Lawyer Interviews

FDA Black Box Warning Adds Fuel to Invokana Lawsuits

FDA Black Box Warning Adds Fuel to Invokana Lawsuits June 24, 2017. By Brenda Craig.
Philadelphia, PA Final results from two independent clinical trials indicate the amputation risk for users of the Type 2 Diabetes drug Canagliflozin, marketed as Invokana, Invokamet, Invokamet XR, are much greater than previously understood.
Read [ FDA Black Box Warning Adds Fuel to Invokana Lawsuits ]

Invokana Goes to Court in Canada

Invokana Goes to Court in Canada March 24, 2016. By Brenda Craig.
Scarborough, ON: Rosalba Joudry had been prescribed a drug called Invokana to help deal with the high glucose levels related to her type 2 diabetes. She had been using the drug for several months when she saw an American TV commercial about a class-action suit filed against Janssen Pharmaceuticals, Inc. Janssen’s new, preeminent diabetes drug had been linked to cases of ketoacidosis or kidney failure, and even death, in users of Invokana, and affected users had joined together in a lawsuit.
Read [ Invokana Goes to Court in Canada ]

FDA Warning Prompts Invokana Lawsuit Investigation

FDA Warning Prompts Invokana Lawsuit Investigation August 11, 2015. By Heidi Turner.
Dallas, TX It’s been only two years since Invokana was approved to treat type 2 diabetes, but in that time the US Food and Drug Administration (FDA) has received more than 450 adverse event reports involving Invokana side effects. Now, attorneys are investigating possible Invokana lawsuits, noting that at least one serious side effect is not yet mentioned on the drug’s label.
Read [ FDA Warning Prompts Invokana Lawsuit Investigation ]

Request Legal Help Now! - Free